Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

NCT01776307 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.

NCT NCT01776307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01776307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Lead sponsor
Sumitomo Pharma America, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
April 30, 2020
Enrollment
200 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer